Pages that link to "Q34352278"
Jump to navigation
Jump to search
The following pages link to A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors (Q34352278):
Displaying 5 items.
- An Unusual Role for a Mobile Flavin in StaC-like Indolocarbazole Biosynthetic Enzymes (Q27670926) (← links)
- Phase I Clinical Trials in Patients ≥80 (Q34990971) (← links)
- Natural Products Diversity of Marine Ascidians (Tunicates; Ascidiacea) and Successful Drugs in Clinical Development. (Q37650544) (← links)
- Microbial natural products: molecular blueprints for antitumor drugs. (Q38133765) (← links)
- Topo2A as a prognostic biomarker for patients with resectable esophageal squamous cell carcinomas (Q44217410) (← links)